AHFS Drug Information 2004 PDF Download

Author: Gerald K. McEvoy
Publisher:
ISBN: 9781585280582
Category : Clinical pharmacology
Languages : en
Pages : 0

View

Book Description

Author: American Society of Health System Pharmacists
Publisher:
ISBN: 9781585286119
Category :
Languages : en
Pages : 840

View

Book Description

Author:
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 1278

View

Book Description

Author: ASHP
Publisher:
ISBN: 9781585286843
Category : Medical
Languages : en
Pages : 0

View

Book Description
AHFS Drug Information® 2022 contains the most dependable drug information available-all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses. With expanded and revised content supported by more than 97,000 references and incorporating the advice of numerous subject matter experts, AHFS DI helps you protect your patients and your practice. Updates in the new edition: The latest information on COVID-19 vaccines and COVID-19 monoclonal antibodies available under FDA Emergency Use Authorizations (EUAs), including clinical considerations from the US Centers for Disease Control and Prevention (CDC), and National Institutes of Health (NIH). Information on patient selection and appropriate use of corticosteroids in the management of COVID-19 based on recent guidelines from NIH and the World Health Organization (WHO). Contemporary issues such as anticoagulant reversal strategies and use of direct oral anticoagulants versus warfarin for treatment of venous thromboembolism or atrial fibrillation. Current best practices such as reversal of neuromuscular blocking agents for prevention of postoperative residual neuromuscular blockade. Newly published information on breakthrough oncology drugs approved as part of the FDA's accelerated approval program. Expanded content on off-label uses, real-world data, and long-term clinical data. Updated information on pharmacogenomic considerations based on recommendations from the Clinical Pharmacogenetics Implementation Consortium (CPIC). Addition of 51 new molecular entities (NMEs) or new therapeutic biological products approved since January 2021.

Author: Claude J. Gaebelein
Publisher: Lippincott Williams & Wilkins
ISBN: 9780781782807
Category : Medical
Languages : en
Pages : 388

View

Book Description
This innovative textbook teaches the basics of drug information, literature evaluation, and biostatistics, and relates these topics to evidence-based pharmaceutical care. Readers will learn what to look for in studies, how to critique them, and how to apply them in clinical pharmacy practice. A major focus is critical appraisal of evidence derived from different types of studies—cases, cohorts, surveys, randomized controlled clinical trials, pharmacoeconomic studies, and systematic reviews. Concluding chapters discuss clinical decision-making using evidence from studies.

Author: A. C. Moffat
Publisher:
ISBN:
Category : Analytical toxicology
Languages : en
Pages : 680

View

Book Description
This manual and reference work provides a source of analytical data for drugs and related substances. It is intended for scientists faced with the difficult problem of identifying a drug in a pharmaceutical product, in a sample of tissue or body fluid, from a living patient or in post-mortem material. Volume One contains 32 chapters covering the practice of and analytical procedures used in forensic toxicology. Volume Two contains over 1750 drug and related substance monographs detailing: physical properties; analytical methods; pharmacokinetic data; and toxicity data, as well as expanded indexes and appendices. These volumes should be useful for all forensic and crime laboratories, toxicologists and analytical chemists, pathologists, poison information centres and clinical pharmacology departments.

Author: Patrick M. Malone
Publisher: McGraw Hill Professional
ISBN: 0071492038
Category : Medical
Languages : en
Pages : 907

View

Book Description
Extensive coverage of the Internet as a source of and distribution means for drug information, and detailed sections on evaluating medical literature from clinical trials Audience includes Pharmacists, Pharmacy students and Pharmacy schools Updated to include using PDAs for medication information Covers the ethical and legal aspects of drug information management Nothing else like it on the market

Author: Gerald K. McEvoy
Publisher:
ISBN: 9781585281039
Category : Medical
Languages : en
Pages : 1544

View

Book Description

Author: Sean C. Sweetman
Publisher:
ISBN: 9780853697046
Category : Medical
Languages : en
Pages : 3335

View

Book Description
This is thirty-fifth edition of Martindale, which provides reliable, and evaluated information on drugs and medicines used throughout the world. It contains encyclopaedic facts about drugs and medicines, with: 5,500 drug monographs; 128,000 preparations; 40,700 reference citations; 10,900 manufacturers. There are synopses of disease treatments which enables identification of medicines, the local equivalent and the manufacturer. It also Includes herbals, diagnostic agents, radiopharmaceuticals, pharmaceutical excipients, toxins, and poisons as well as drugs and medicines. Based on published information and extensively referenced

Author: Virginia Poole Arcangelo
Publisher: Lippincott Williams & Wilkins
ISBN: 9780781757843
Category : Medical
Languages : en
Pages : 988

View

Book Description
This advanced pharmacotherapeutics text for nurse practitioners and physician assistants offers guidelines on prescribing drugs for over 50 common diseases and disorders. The book is organized by disorder rather than drug class and includes algorithms and case studies that illustrate critical thinking aspects of prescribing, such as drug selection, lifespan considerations, therapeutic drug monitoring, adverse reactions, unexpected outcomes, and when to change therapy. This Second Edition has new chapters on oncologic disorders and complementary and alternative medicines. Improved case studies reflect more realistic practice issues in decision-making. Additional areas addressed include food-drug interactions, dietary considerations, and concerns regarding geriatric patients.